Noosa News
Brisbane company wins European approval for rapid COVID-19 tests
A Brisbane-based firm has won approval from European regulators to sell its 15-minute COVID-19 rapid test.
The company, AnteoTech, has been given the Conformitè Europëenne Mark registration for its antigen rapid test, EuGeni.
AnteoTech chief executive Derek Thomson.
The reusable test, which now meets crucial health and safety conditions in Europe and the United Kingdom, is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the…
-
General23 hours agoThis isn’t progress, it’s punishment
-
General22 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I
-
General21 hours agoNothing to see here *wink wink*
-
General20 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup